LimFlow, Inc. clinical trials
Acquired by Stryker, Feb 19, 2025 · source ↗
The registry lists 6 studies whose lead sponsor is LimFlow, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 16, 2026.
Before and after it joined Stryker
- First submitted before LimFlow, Inc. became part of Stryker
- 6
- First submitted after LimFlow, Inc. became part of Stryker
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- LimFlow, Inc.4 studies
- LimFlow SA2 studies
Something wrong with this grouping? Tell us on the Stryker page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Stryker studies →
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaRecruitingNCT05313165Not applicable
Sponsor listed in the registry: LimFlow, Inc. · First submitted before LimFlow, Inc. became part of Stryker
- Percutaneous Deep Vein Arterialization Post-Market StudyCompletedNCT03807661Not applicable
Sponsor listed in the registry: LimFlow SA · First submitted before LimFlow SA became part of Stryker
- PROMISE InternationalCompletedNCT03321552Not applicable
Sponsor listed in the registry: LimFlow SA · First submitted before LimFlow SA became part of Stryker
- Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI StudyCompletedNCT04304105
Sponsor listed in the registry: LimFlow, Inc. · First submitted before LimFlow, Inc. became part of Stryker
- PROMISE I Early Feasibility Trial of the LimFlow Stent Graft SystemCompletedNCT03124875Not applicable
Sponsor listed in the registry: LimFlow, Inc. · First submitted before LimFlow, Inc. became part of Stryker
- PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaActive, not recruitingNCT03970538Not applicable
Sponsor listed in the registry: LimFlow, Inc. · First submitted before LimFlow, Inc. became part of Stryker